Product List
Enasidenib | 1446502-11-9
Enasidenib is an inhibitor of IDH2. It is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of th……
Enasidenib Intermediate,1446507-38-5 | 1446507-38-5
Enasidenib is an inhibitor of IDH2. It is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of th……
Fostamatinib disodium | 1025687-58-4
"
Fostamatinib is an experimental drug candidate for the treatment of a variety of diseases, originally developed by Rigel Pharmaceuticals. The drug……
Fostamatinib intermediate 1 | 901119-38-8
"
Fostamatinib is an experimental drug candidate for the treatment of a variety of diseases, originally developed by Rigel Pharmaceuticals. The drug……
Fostamatinib intermediate 2 | 841290-80-0
"
Fostamatinib is an experimental drug candidate for the treatment of a variety of diseases, originally developed by Rigel Pharmaceuticals. The drug……
Fostamatinib intermediate 3 | 1002726-59-1
"
Fostamatinib is an experimental drug candidate for the treatment of a variety of diseases, originally developed by Rigel Pharmaceuticals. The drug……
Ribociclib | 1211441-98-3
"
Ribociclib (trade name Kisqali) is an inhibitor of cyclin D1/CDK4 and CDK6, and is used for the treatment of certain kinds of breast cancer. It is……
Ribociclib intermediate 1 | 1374639-78-7
"
Ribociclib (trade name Kisqali) is an inhibitor of cyclin D1/CDK4 and CDK6, and is used for the treatment of certain kinds of breast cancer. It is……
Ribociclib intermediate 2 | 1211443-61-6
"
Ribociclib (trade name Kisqali) is an inhibitor of cyclin D1/CDK4 and CDK6, and is used for the treatment of certain kinds of breast cancer. It is……